FDA Approves UNLOXCYT™ Label Update, Enhancing Treatment for Advanced Skin Cancer#United_States#Princeton#UNLOXCYT#cosibelimab#squamous_cell
FDA Approves UNLOXCYT™ Label Update, Enhancing Treatment for Advanced Skin Cancer
The FDA has updated the label for UNLOXCYT™, an innovative treatment for advanced squamous cell carcinoma, showcasing improved outcomes based on long-term data.
third-news.com
November 26, 2025 at 4:04 AM
FDA Approves UNLOXCYT™ Label Update, Enhancing Treatment for Advanced Skin Cancer#United_States#Princeton#UNLOXCYT#cosibelimab#squamous_cell